What drove this pharmaceutical stock's 4% increase today? Find out here!

Q: How long will it take to read this news story?

The story "What drove this pharmaceutical stock&#039;s 4% increase today? Find out here!" has 510 words across 22 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "What drove this pharmaceutical stock&#039;s 4% increase today? Find out here!" was covered 4 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 227 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22783429</li><li>URL: https://beamstart.com/news/what-drove-this-pharmaceutical-stocks-172767613975</li></ul>

Business Standard Logo Business Standard 4h ago

What drove this pharmaceutical stock's 4% increase today? Find out here! - Business Standard

Quick Summary:

Alembic Pharma share price surged after the USFDA issued establishment inspection report (EIR) for the inspection carried out at the company's Oral Solid Formulation Facility (F-I).

The company manufactures and markets a diverse range of products, including formulations for the Indian market produced in Sikkim, international generics made in Gujarat, and active pharmaceutical ingredients (APIs) also manufactured in Gujarat.

Alembic Pharmaceuticals Limited is a pharmaceutical company headquartered in Vadodara, Gujarat.